Compositions and methods for diagnosing or treating psoriasis
CA 2604066 A1 · Owner: Celltech R & D, Inc. · Inventors: Mceuen, Mark; Moss, Patrick; Charmley, Patrick
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
In one aspect, the present invention provides isolated nucleic acid molecules that , encode a CAN-1 polypeptide, or an STG polypeptide. In another aspect the , present , invention also provides isolated STG polypeptides isolated CAN-1 , polypeptides, and , isolated SEEK-1 polypeptides. In another aspect the present invention , provides isolated antibodies that bind specifically to a CAN-1 SEEK-1 or STG polypeptide. In , another aspect, the present invention provides methods of diagnosing or predicting the susceptibility to psoriasis of an individual. In another aspect the present , invention , provides methods for ameliorating the symptoms and/or progression of psoriasis.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed November 27, 2001. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended November 27, 2021.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by November 27, 2023.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.